Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lefamulin Phase 2 in ABSSSI
NCT01119105Phase 2Completed
- Sponsor
- Nabriva Therapeutics plc
- Start
- May 2010
- Primary completion
- Dec 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lefamulin in acute bacterial skin and skin structure infection (ABSSSI), sponsored by Nabriva Therapeutics plc. Started May 2010; status: completed.
02
Drugs
lefamulin
03
Conditions
acute bacterial skin and skin structure infection (ABSSSI)
Beyond the preview
Go deeper on NCT01119105.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01119105.